Clover Health Investments (CLOV) Accounts Payables (2020 - 2026)

Clover Health Investments has reported Accounts Payables for 7 years, with the latest figure at $39.2 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 28.2% year-over-year to $39.2 million; the trailing twelve-month figure through Mar 2026 stood at $39.2 million (up 28.2% YoY), and the FY2025 full-year result was $36.2 million, up 4.77% from the prior year.
• Accounts Payables for Q1 2026 stood at $39.2 million, up from $36.2 million in the prior quarter.
• The five-year high for Accounts Payables was $47.5 million in Q1 2023, with the low at $11.2 million in Q1 2022.
• Historically, Accounts Payables has averaged $27.3 million across 5 years, with a median of $32.9 million in 2025.
• Annual changes were most pronounced in 2023 — Accounts Payables jumped 323.68% — and 2024, when it plunged 68.81%.
• Clover Health Investments' Accounts Payables stood at $14.3 million in 2022, then soared by 160.03% to $37.2 million in 2023, then fell by 7.05% to $34.6 million in 2024, then advanced by 4.77% to $36.2 million in 2025, then gained by 8.17% to $39.2 million in 2026.
• The last three Accounts Payables figures came in at $39.2 million (Q1 2026), $36.2 million (Q4 2025), and $32.9 million (Q3 2025), per Business Quant data.